Jenna Ventorino is an up-and-coming corporate lawyer who provides ongoing counsel to public and private technology and life sciences companies. She advises clients in the biotechnology, software, telecommunications and clean technology industries in complex transactions including mergers and acquisitions, intellectual property licensing and private securities offerings. She draws on her prior experience as in-house counsel to help her clients navigate their legal and business challenges.
In addition to advising clients on a wide range of corporate and securities matters, Ms. Ventorino advises clients on various licensing transactions including joint venture arrangements, strategic alliances and other collaboration deals. She negotiates on collaboration, development, distribution, license and service agreements with customers, suppliers, licensors, licensees and other third parties, and on the acquisition and sale of intellectual property or other technology.
Ms. Ventorino counsels emerging companies throughout their lifecycle and in venture capital financings and exit transactions. She also has experience representing private and institutional investors in private investments and related transactions.
Ms. Ventorino is an active member of WilmerHale's Women's Leadership Initiative and leads the east coast's Female Founders initiative—an effort that brings awareness to the issues facing leaders and executives from women-led startup businesses.
In addition, she is a member of the Boston Bar Association, Women's Bar Association, the Cornell University Alumni Ambassador Association and an alumni mentor for the Boston University School of Law. She is a former board member of the Cornell University Human Ecology Alumni Association.
Prior to joining the firm, Ms. Ventorino worked as an associate at a business law firm where she negotiated mergers, acquisitions, divestitures and other strategic transactions; drafted agreements related to software and patent licensing; provided IP consulting services; and advised on IP-centered strategic transactions and joint ventures. Ms. Ventorino also worked with private companies, venture capital firms and other investors to structure and negotiate debt and equity financings.
Ms. Ventorino previously worked as an attorney for Kenexa Technology, Inc. (formerly Salary.com, Inc.), where she managed the compensation division.
Ms. Ventorino represents private companies in various stages of development, publicly traded companies, and investment firms that have a particular focus on tech and life sciences. She has represented:
- Aileron Therapeutics, Inc. in its initial public offering;
- Affirmed Networks, Inc. in its acquisition of Hitachi Communication Technologies America, Inc.;
- American Express in participating agreements for AndroidPay and SamsungPay;
- Editas Medicine in its strategic alliance and option agreement with Allergan;
- Spark Therapeutics in its synthetic vaccine particles licensing transaction with Selecta Biosciences, and in its licensing agreement with Novartis Pharmaceuticals to develop and commercialize investigational voretigene neparvovec outside the United States;
- numerous companies in venture capital and private financings, including Aileron Therapeutics, Daktari Diagnostics, Jebbit, Nantero and RightHand Robotics; and
- venture capital firms including MPM Capital and Spark Capital in various private placement financings and strategic investments.
Honors & Awards
- Named a 2017 Massachusetts Rising Star by Super Lawyers for her business/corporate and technology transactions practices
- Selected to participate in the 2015-2016 Women's Bar Association Women's Leadership Initiative
Insights & News
JD, Boston University School of Law, 2008cum laude Editor, American Journal of Law and Medicine
MS, Family, Queens College, City University of New York, 2004
BS, Nutritional Science, Cornell University, 1999Phi Eta Sigma National Honor Society